India's cough syrup ban hits Pfizer, Abbott units
Their products are among 344 fixed-dose combination drugs prohibited by regulators
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Mumbai
PFIZER Inc and Abbott Laboratories on Monday said they would comply with a ban on a popular cough syrup in India after it was added to a local list of prohibited drugs, sending shares in the US firms' Indian subsidiaries tumbling.
Pfizer's Corex-brand syrup and Abbott's identical Phensedyl contain the narcotic codeine. That brought them to the attention of authorities combating addiction and smuggling, who had been privately pressuring the drugmakers to better police supply chains, Reuters reported last year.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
